RxWare key facts
as of Oct 2026- Developer of a digital platform designed for connecting patients with essential services.
- RxWare is valued at approximately $19.5M as of Oct 2026 (last reported valuation).
- It has raised $13.8M across 2 recorded rounds; the latest was Early Stage VC ($6.1M) in Aug 2025.
- Notable investors include Adam Fine, Calin Fusu, Chris Bergstrom, ConnectiveRx, IBM Alpha Zone Accelerator — 18 tracked in total.
- RxWare has filed 3 Form Ds with the SEC since 2024, most recently Aug 2025 ($6.1M sold to 12 investors).
- Status: Privately Held (backing).
RxWare's last reported valuation, Jan 2020. Nothing priced has surfaced since.
- ·The complete investor list: 18 names
- ·Watch RxWare: the Monday email on marks, rounds and moves
RxWare funding rounds
2 roundsWho backs RxWare
18+RxWare valuation
RxWare's last reported valuation was $19.5 million in Jan 2020. No priced round, secondary trade or fund mark has surfaced since.
How much has RxWare raised?
RxWare has raised $13.8 million in total; 2 of its rounds are on record. The largest on record was a $700,000 seed round in Apr 2024; the most recent was a $6.1 million early-stage round in Aug 2025.
RxWare has filed 3 Form Ds with the SEC since 2024, most recently in Aug 2025 ($6.1 million sold to 12 investors).
RxWare investors
18 investors are on record for RxWare, including Adam Fine, Calin Fusu, Chris Bergstrom and ConnectiveRx. The early-stage round in Aug 2025 drew 12 investors.
About RxWare
Developer of a digital platform designed for connecting patients with essential services. The company's platform is flexible, scalable and secure to enhance patient engagement throughout the entire specialty prescription journey, enabling pharmaceutical brands to improve patient lives.
- Sector
- Healthcare
- HQ
- Wilmington, DE, United States
- Founded
- 2013
- Employees
- 30
- Website
- rxware.io/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.